Drug Repurposing for the SARS-CoV-2 Papain-Like Protease (vol 17, 202100455, 2022)

被引：1
|
作者：
Cho, Chia-Chuan
Li, Shuhua G.
Lalonde, Tyler J.
Yang, Kai S.
Yu, Ge
Qiao, Yuchen
Xu, Shiqing
Ray Liu, Wenshe
机构：
来源：
CHEMMEDCHEM | 2022年 / 17卷 / 05期
关键词：
COVID-19; SARS-CoV-2; papain-like protease; deubiquitinase; cysteine protease;
D O I：
10.1002/cmdc.202200053
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Drug Repurposing for the SARS-CoV-2 Papain-Like Protease
    Cho, Chia-Chuan
    Li, Shuhua G.
    Lalonde, Tyler J.
    Yang, Kai S.
    Yu, Ge
    Qiao, Yuchen
    Xu, Shiqing
    Ray Liu, Wenshe
    CHEMMEDCHEM, 2022, 17 (01)
  • [2] Drug-Repurposing Screening Identified Tropifexor as a SARS-CoV-2 Papain-like Protease Inhibitor
    Ma, Chunlong
    Hu, Yanmei
    Wang, Yuyin
    Choza, Juliana
    Wang, Jun
    ACS INFECTIOUS DISEASES, 2022, 8 (05): : 1022 - 1030
  • [3] Crystal structure of SARS-CoV-2 papain-like protease
    Gao, Xiaopan
    Qin, Bo
    Chen, Pu
    Zhu, Kaixiang
    Hou, Pengjiao
    Wojdyla, Justyna Aleksandra
    Wang, Meitian
    Cui, Sheng
    ACTA PHARMACEUTICA SINICA B, 2021, 11 (01) : 237 - 245
  • [4] The SARS-CoV-2 SSHHPS Recognized by the Papain-like Protease
    Reynolds, Nathanael D.
    Aceves, Nathalie M.
    Liu, Jinny L.
    Compton, Jaimee R.
    Leary, Dagmar H.
    Freitas, Brendan T.
    Pegan, Scott D.
    Doctor, Katarina Z.
    Wu, Fred Y.
    Hu, Xin
    Legler, Patricia M.
    ACS INFECTIOUS DISEASES, 2021, 7 (06): : 1483 - 1502
  • [5] Crystal structure of SARS-CoV-2 papain-like protease
    Xiaopan Gao
    Bo Qin
    Pu Chen
    Kaixiang Zhu
    Pengjiao Hou
    Justyna Aleksandra Wojdyla
    Meitian Wang
    Sheng Cui
    Acta Pharmaceutica Sinica B, 2021, 11 (01) : 237 - 245
  • [6] Review of the crystallized structures of the SARS-CoV-2 papain-like protease
    Qiu, Yue
    Jiang, Hua-Juan
    Yang, Yu-Shun
    Hu, Xiao-Qin
    Zeng, Xue-Wen
    JOURNAL OF MOLECULAR STRUCTURE, 2025, 1333
  • [7] Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2
    Klemm, Theresa
    Ebert, Gregor
    Calleja, Dale J.
    Allison, Cody C.
    Richardson, Lachlan W.
    Bernardini, Jonathan P.
    Lu, Bernadine G. C.
    Kuchel, Nathan W.
    Grohmann, Christoph
    Shibata, Yuri
    Gan, Zhong Yan
    Cooney, James P.
    Doerflinger, Marcel
    Au, Amanda E.
    Blackmore, Timothy R.
    van der Heden van Noort, Gerbrand J.
    Geurink, Paul P.
    Ovaa, Huib
    Newman, Janet
    Riboldi-Tunnicliffe, Alan
    Czabotar, Peter E.
    Mitchell, Jeffrey P.
    Feltham, Rebecca
    Lechtenberg, Bernhard C.
    Lowes, Kym N.
    Dewson, Grant
    Pellegrini, Marc
    Lessene, Guillaume
    Komander, David
    EMBO JOURNAL, 2020, 39 (18):
  • [8] Targeting SARS-CoV-2 papain-like protease in the postvaccine era
    Ton, Anh-Tien
    Pandey, Mohit
    Smith, Jason R.
    Ban, Fuqiang
    Fernandez, Michael
    Cherkasov, Artem
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2022, 43 (11) : 906 - 919
  • [9] Ciclesonide Inhibits SARS-CoV-2 Papain-Like Protease in Vitro
    Kiba, Yuka
    Tanikawa, Takashi
    Kitamura, Masashi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2024, 47 (05) : 965 - 966
  • [10] Validation and Invalidation of SARS-CoV-2 Papain-like Protease Inhibitors
    Ma, Chunlong
    Wang, Jun
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2022, 5 (02) : 102 - 109
12345